Impact of COVID-19 on cardiovascular diseases: experience at a teaching hospital from rural Telangana

Archana Santosh Jain, Swaralee Khedkar, Madhavi Jangala


Background: COVID-19 is drastically affecting the health of millions of people globally. Further, the restrictions imposed during lockdowns to curtail the spread of COVID-19 have also shown impact on the economy, psychology and lifestyle of the people. However, little is known about the prevalence and clinical manifestations of COVID-19 in coronary heart diseases in rural India. Hence, the present study aimed to find the effect of COVID-19 and lockdown on the prevalence of coronary heart diseases in rural Telangana.

Methods: The present retrospective study was carried on 1320 medical reports of cardiac inpatients who visited RVM Institute of Medical Sciences and Research Center, Siddipet, Telangana during the period 17th January 2020 to 6th August 2020. The data obtained was analyzed by descriptive statistics using IBM SPSS Statistics version 21.0.

Results: Admission of patients with STEMI (53.6% prelockdown; 26% lockdown period; 36.4% post lockdown) and arrhythmia (7.3% prelockdown; 1.3% post lockdown) decreased while there was a significant increase in hospitalization of myopericarditis patients (1% pre lockdown vs. 10.5% lock down, 9.2% post lockdown) after the initiation of lockdown period. Further, STEMI (mean age 42.07±15.06) and myopericarditis (mean age 30.8±9.02 years) was commonly seen in younger age group patients less than 45 years after the initiation of lockdown period. The mortality rate was 6.6% (n=13) in the total study period of which 57.5% (n=7) deaths were due to myocardial infarction. 63.6% of the cardiac patients tested by RT-PCR were found to be positive for COVID-19.

Conclusions: The prevalence of cardiovascular diseases varied with lockdown periods. Young adults in rural Telangana were also affected by COVID-19 and lockdown.


Arrhythmia, Acute cor pulmonale, Acute coronary syndrome, COVID-19, Left ventricular, Left anterior descending artery

Full Text:



Fried JA, Ramasubbu K, Bhatt R. The variety of cardiovascular presentations of COVID-19. Circulation. 2020;141(23):1930-6.

Dabbagh MF, Aurora L, D’Souza P, Weinmann AJ, Bhargava P, Basir MB. Cardiac Tamponade Secondary to COVID-19. JACC: Case Reports. 2020;2(9):1326-30.

Driggin E, Madhavan MV, Bikdeli B. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am College Cardiol. 2020;75(18):2352-71.

Hendren NS, Drazner MH, Bozkurt B, Cooper LT. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation. 2020;141(23):1903-14.

Shi S. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;23:41-9.

Public Information Bureau. Available at: Accessed on 20 October 2021.

Mahmud E, Dauerman HL, Welt FG. Management of acute myocardial infarction during the COVID ‐19 pandemic. Catheter Cardiovasc Interv. 2020;96(2):336-45.

Guha S, Mukhopadhay S, Karak A, Choudhury B, Kapoor A, Yadav R. Managing ACS during COVID-19 infection: Do not follow the traditional route. Indian Heart J. 2020;72(2):128-30.

Treating only emergencies, state order issued, Govt of Telangana. Available at: https://www.telangana. Accessed on 20 October 2021.

Document on acute MI care during COVID-19. Available at: https://10.1016/J.ihj.2020,04.009. Accessed on 20 October 2021.

Mahmud E. Management of acute myocardial infarction during the COVID ‐19 pandemic.” Catheter Cardiovasc Intervent. 2020;96(2):336-45.

Szekely Y, Lichter Y, Taieb P. Spectrum of cardiac manifestations in COVID-19. Circulation. 2020;142(4):342-53.

Filippo O de, D’Ascenzo F, Angelini F. Reduced rate of hospital admissions for ACS during Covid-19 Outbreak in Northern Italy. N Engl J Med. 2020;383(1):88-9.

Solomon MD, McNulty EJ, Rana JS. The Covid-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med. 2020;383(7):691-3.

Garcia S, Albaghdadi MS, Meraj PM. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am College Cardiol. 2020;75(22):2871-2.

Li Y-H, Huang W-C, Hwang J-J. No reduction of ST-segment elevation myocardial infarction admission in Taiwan during coronavirus pandemic. Am J Cardiol. 2020;131:133-4.

Chan DZ, Stewart RA, Kerr AJ. The impact of a national COVID-19 lockdown on acute coronary syndrome hospitalisations in New Zealand (ANZACS-QI 55). Lancet. 2020;5:100056.

Chow EJ, Rolfes MA, O’Halloran A. Respiratory and nonrespiratory diagnoses associated with influenza in hospitalized adults. JAMA. 2020;3(3):e201323.

Odone A, Delmonte D, Scognamiglio T, Signorelli C. COVID-19 deaths in Lombardy, Italy: data in context. Lancet Public Health. 2020;5(6):e310.

Marijon E. Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study. Lancet Public health. 2020;5(8):e437-43.

Richardson S, Hirsch JS, Narasimhan M. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052.

Stefanini GG, Azzolini E, Condorelli G. Critical organizational issues for cardiologists in the COVID-19 Outbreak. Circulation. 2020;141(20):1597-9.

Moroni F, Gramegna M, Ajello S. Collateral Damage. JACC. 2020;2(10):1620-4.

Pessoa-Amorim G, Camm CF, Gajendragadkar P. Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology. Eur Heart J Qual Care Clin Outcomes. 2020;6(3):210-6.

Sattar Y, Ullah W, Rauf H. COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management. IJC Heart Vascul. 2020;29:100589.

Li X, Pan X, Li Y, An N, Xing Y, Yang F. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review. Crit Care. 2020;24:468.

Bangalore S, Sharma A, Slotwiner A. ST-segment elevation in patients with COVID-19-A Case Series. N Engl J Med. 2020;382(25):2478-80.

Creel-Bulos C, Hockstein M, Amin N, Melhem S, Truong A, Sharifpour M. Acute Cor Pulmonale in Critically Ill Patients with Covid-19. N Engl J Med. 2020;382(21):e70.

Inciardi RM, Lupi L, Zaccone G. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819.

Casey K, Iteen A, Nicolini R, Auten J. COVID-19 pneumonia with hemoptysis: Acute segmental pulmonary emboli associated with novel coronavirus infection. Am J Emerg Med. 2020;38(7):1544.e1-3.

Ahmed T, Ahmed T, Kumar S, Lodhi SH, Akbik B. Rare presentation of pulmonary embolism amidst coronavirus disease 2019 era: utility of multiorgan ultrasonography. Cureus. 2020;22:21-8.

Hessami A, Shamshirian A, Heydari K. Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis. Am J Emerg Med. 2021;46:382-91.

Kumar M, Tyagi N, Arora M. Management of ST elevation myocardial infarction (STEMI) with primary angioplasty in Covid 19 lockdown. Indian Heart J. 2020;72(4):325-6.

Patil RS, Shetty LH, Krishnan S, Trivedi AS, Raghu TR, Manjunath CN. Profile of coronary artery disease in indian rural youth (<35 years). Indian Heart J. 2020;72(5):394-7.

Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543-58.

Daniels MJ, Cohen MG, Bavry AA, Kumbhani DJ. Reperfusion of ST-Segment–Elevation Myocardial Infarction in the COVID-19 Era. Circulation. 2020;141(24):1948-50.

Woolf SH, Chapman DA, Sabo RT, Weinberger DM, Hill L, Taylor DDH. Excess deaths from COVID-19 and other causes, March-July 2020. JAMA. 2020;324(15):1562.

Bonow RO, Fonarow GC, O’Gara PT, Yancy CW. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol. 2020;5(7):751.

Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: Possible mechanisms. Life Sci. 2020;253:117723.

Zhou F, Yu T, Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.

Jain VK, Iyengar K, Vaish A, Vaishya R. Differential mortality in COVID-19 patients from India and western countries. Diab Metab Synd Clin Res Rev. 2020;14(5):1037-41.

Peter D. Covid-19: do many people have pre-existing immunity? BMJ. 2020;325:63-9.